TF and COVID-19: In another study involving COVID-19 patients in ICU, transferrin levels showed non-significant subtle alterations (both increment and decrement) through the period of 18 days in ICU, with subtly higher levels on days 15–18 compared to days 1–2 of the ICU stay.